Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer science

Showing results (1051-1060 of 6,943) with videos related to

Pageof 695
Sort By:
Cancer Science|May 30, 2007
Organ-dependent susceptibility of p53 knockout mice to 2-amino-3-methylimidazo[4,5-f]quinoline (IQ)Akihiro Hirata, Tetsuya Tsukamoto, Masami Yamamoto, et al.
Cancer Science|May 25, 2007
Minor histocompatibility antigens as targets for immunotherapy using allogeneic immune reactionsYoshiki Akatsuka, Yasuo Morishima, Kiyotaka Kuzushima, et al.
Cancer Science|May 1, 2007
Strong suppression of tumor growth by insulin-like growth factor-binding protein-related protein 1/tumor-derived cell adhesion factor/mac25Yuichiro Sato, Zhaoxin Chen, Kaoru Miyazaki
Cancer Science|April 17, 2007
Cross-species difference in telomeric function of tankyrase 1Yukiko Muramatsu, Tomokazu Ohishi, Michiko Sakamoto, et al.
Cancer Science|May 15, 2007
Antibody-dependent cellular cytotoxicity of cetuximab against tumor cells with wild-type or mutant epidermal growth factor receptorHideharu Kimura, Kazuko Sakai, Tokuzo Arao, et al.
Cancer Science|May 22, 2007
Cytokine production of lung cancer cell lines: Correlation between their production and the inflammatory/immunological responses both in vivo and in vitroTakashi Fukuyama, Yoshinobu Ichiki, Sousuke Yamada, et al.
Cancer Science|June 1, 2006
Phase I/II adenoviral p53 gene therapy for chemoradiation resistant advanced esophageal squamous cell carcinomaHideaki Shimada, Hisahiro Matsubara, Tooru Shiratori, et al.
Cancer Science|October 21, 2006
Multistep carcinogenesis of the colon in Apc(Min/+) mouseYasuhiro Yamada, Hideki Mori
Cancer Science|October 21, 2006
Cancer research with non-coding RNAYasuhiro Tomaru, Yoshihide Hayashizaki
Cancer Science|October 13, 2006
Anti-tumor effect in an in vivo model by human-derived pancreatic RNase with basic fibroblast growth factor insertional fusion protein through antiangiogenic propertiesHiroshi Yagi, Masakazu Ueda, Hiromitsu Jinno, et al.
Pageof 695

Showing results (1051-1060 of 6,943) with videos related to

Sort By:
Pageof 695
Cancer Science|May 30, 2007
Organ-dependent susceptibility of p53 knockout mice to 2-amino-3-methylimidazo[4,5-f]quinoline (IQ)Akihiro Hirata, Tetsuya Tsukamoto, Masami Yamamoto, et al.
Cancer Science|May 25, 2007
Minor histocompatibility antigens as targets for immunotherapy using allogeneic immune reactionsYoshiki Akatsuka, Yasuo Morishima, Kiyotaka Kuzushima, et al.
Cancer Science|May 1, 2007
Strong suppression of tumor growth by insulin-like growth factor-binding protein-related protein 1/tumor-derived cell adhesion factor/mac25Yuichiro Sato, Zhaoxin Chen, Kaoru Miyazaki
Cancer Science|April 17, 2007
Cross-species difference in telomeric function of tankyrase 1Yukiko Muramatsu, Tomokazu Ohishi, Michiko Sakamoto, et al.
Cancer Science|May 15, 2007
Antibody-dependent cellular cytotoxicity of cetuximab against tumor cells with wild-type or mutant epidermal growth factor receptorHideharu Kimura, Kazuko Sakai, Tokuzo Arao, et al.
Cancer Science|May 22, 2007
Cytokine production of lung cancer cell lines: Correlation between their production and the inflammatory/immunological responses both in vivo and in vitroTakashi Fukuyama, Yoshinobu Ichiki, Sousuke Yamada, et al.
Cancer Science|June 1, 2006
Phase I/II adenoviral p53 gene therapy for chemoradiation resistant advanced esophageal squamous cell carcinomaHideaki Shimada, Hisahiro Matsubara, Tooru Shiratori, et al.
Cancer Science|October 21, 2006
Multistep carcinogenesis of the colon in Apc(Min/+) mouseYasuhiro Yamada, Hideki Mori
Cancer Science|October 21, 2006
Cancer research with non-coding RNAYasuhiro Tomaru, Yoshihide Hayashizaki
Cancer Science|October 13, 2006
Anti-tumor effect in an in vivo model by human-derived pancreatic RNase with basic fibroblast growth factor insertional fusion protein through antiangiogenic propertiesHiroshi Yagi, Masakazu Ueda, Hiromitsu Jinno, et al.
Pageof 695